# Neosense Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neosense-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Stockholm, Sweden
- Website: www.neosen.se
- Total disclosed funding: $0.3M
- Latest round: Seed (Oct 23, 2017)
- Investors on record: 2

## About

Neosense Technologies AB is a Swedish company specializing in advanced medical technology, providing innovative solutions for continuous oxygen monitoring in critical care environments, particularly focusing on neonatal care.Founded in 2014 in Stockholm, Sweden, Neosense Technologies AB develops advanced medical devices for oxygen monitoring, specifically targeting the needs of intensive care units. The company was established by Nils Holmström. In October 2017, Neosense raised SEK 2.8 million in a Seed funding round led by ALMI Invest with participation from KTH Holding, marking its strategic growth in the healthcare sector. The company has completed one total deal since its inception.Neosense Technologies AB specializes in advanced medical technology, primarily focusing on continuous oxygen monitoring systems designed for intensive care units catering to critically ill patients, particularly extremely preterm infants. Their flagship product is a groundbreaking sensor that enables real-time measurement of blood oxygenation, addressing the vital need for precision in oxygen therapy to mitigate the risks of both hypoxia and hyperoxia in neonates. The company's solutions are targeted toward healthcare providers and hospitals, improving neonatal care through enhanced oxygen management. Neosense’s products are marketed in Europe and North America, serving hospitals and neonatal intensive care units that require sophisticated monitoring systems to ensure patient safety and minimize potential adverse outcomes associated with oxygen therapy mismanagement.In 2022, Neosense Technologies AB reported revenue of SEK 796.7 mn. The company also recorded an EBITDA of SEK -37,510.6 mn for the same year, indicating its current financial performance amid ongoing investments in development and market positioning.Looking ahead, Neosense Technologies AB aims to expand its product line by introducing new oxygen monitoring systems designed to enhance neonatal care, with specific launch timelines not disclosed. The company is also targeting growth in additional markets within Europe and North America by leveraging its recent funding. The SEK 2.8 million raised in October 2017 will support these initiatives, facilitating research and development as well as market entry strategies in new regional markets.

## Funding rounds

- Seed, Oct 23, 2017, $0.3M — KTH Holding, ALMI Invest

## Investors

- KTH Holding (https://capitalatlas.ai/funds/kth-holding) — Seed
- ALMI Invest — Seed